{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:20Z","timestamp":1783075940312,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jad.2022.12.107","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T20:03:28Z","timestamp":1672257808000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Relationship between serum concentration and clinical response of quetiapine in adolescents and adults with bipolar disorders in acute stage: a prospective observational study"],"prefix":"10.1016","volume":"324","author":[{"given":"Si","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bo","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Le","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Meng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Meng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.12.107_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.yic.0000188213.46667.f1","article-title":"Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations","volume":"21","author":"Aichhorn","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.107_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/NDT.S4903","article-title":"Role of extended release quetiapine in the management of bipolar disorders","volume":"6","author":"Al Jurdi","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2022.12.107_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1192\/bjp.bp.114.158543","article-title":"Mood instability: significance, definition and measurement","volume":"207","author":"Broome","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0030","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.v68n1011","article-title":"Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service","volume":"68","author":"Castberg","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0035","article-title":"The clinical management of bipolar disorder: a review of evidence-based guidelines","volume":"13","author":"Connolly","year":"2011","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jad.2022.12.107_bb0040","first-page":"58","article-title":"Therapeutic drug monitoring (TDM) of quetiapine","volume":"36","author":"Dragicevic","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0045","doi-asserted-by":"crossref","first-page":"A044","DOI":"10.1055\/s-2005-918666","article-title":"Gender and age effects on quetiapine serum concentrations in patients with schizophrenia or schizoaffective disorders","volume":"38","author":"Dragicevic","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0031-1286291","article-title":"Therapeutic drug monitoring in child and adolescent psychiatry","volume":"44","author":"Egberts","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0055","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2022.12.107_bb0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-972573","article-title":"Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders","volume":"40","author":"Gerlach","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2022.12.107_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2125.2005.02507.x","article-title":"Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics","volume":"61","author":"Grimm","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2022.12.107_bb0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/acps.12408","article-title":"A systematic review and meta-analysis of premature mortality in bipolar affective disorder","volume":"131","author":"Hayes","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.12.107_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1567201812666151029100909","article-title":"Consensus guideline based therapeutic drug monitoring (TDM) in psychiatry and neurology","volume":"13","author":"Hiemke","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jad.2022.12.107_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2165\/00002018-200629090-00001","article-title":"Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance","volume":"29","author":"Jaquenoud Sirot","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.jad.2022.12.107_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0100","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1517\/14656566.8.14.2207","article-title":"Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels","volume":"8","author":"Mauri","year":"2007","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jad.2022.12.107_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.pra.0000336757.42437.fe","article-title":"Practical application of therapeutic drug monitoring: a tale of two patients","volume":"14","author":"Preskorn","year":"2008","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2022.12.107_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.12.107_bb0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4088\/JCP.09r05739yel","article-title":"Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review","volume":"72","author":"Sparshatt","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2022.12.107_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007815.pub2","article-title":"Quetiapine versus typical antipsychotic medications for schizophrenia","author":"Suttajit","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2022.12.107_bb0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jphp.12209","article-title":"Interactions between valproic acid and quetiapine\/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring","volume":"66","author":"Vella","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jad.2022.12.107_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jad.2016.08.062","article-title":"The prevalence of bipolar disorder in China: a meta-analysis","volume":"207","author":"Zhang","year":"2017","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722014690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722014690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:37:33Z","timestamp":1759030653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722014690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"alternative-id":["S0165032722014690"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.107","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between serum concentration and clinical response of quetiapine in adolescents and adults with bipolar disorders in acute stage: a prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}